Apoptosis and hepatobiliary disease

Hepatology

Volumn 21, Issue 6, 1995, Pages 1725-1741

  Patel, Tushar ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CYCLOHEXIMIDE; DIMETHYLNITROSAMINE; ENDONUCLEASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECEPTOR PROTEIN; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; VINYLIDENE CHLORIDE;

APOPTOSIS; AUTOIMMUNITY; HEPATOBILIARY DISEASE; HUMAN; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER NECROSIS; LIVER TOXICITY; MALIGNANT TRANSFORMATION; ONCOGENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ANIMAL; APOPTOSIS; BILIARY TRACT DISEASES; HUMAN; LIVER; LIVER DISEASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029012444     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90481-6     Document Type: Article

References (145)

1. Cell death; the significance of apoptosis
2. Apoptosis: A different type of cell death
3. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics
4. Liver cell necrosis: cellular mechanisms and clinical implications
5. Mechanisms of cell death
6. Apoptosis
7. Programmed cell death: new thoughts and relevance to aging
8. Shrinkage necrosis: a distinct form of cellular death
9. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
10. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
11. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death
12. Genetic control of programmed cell death in the nematode C. elegans
13. Apoptosis: mechanisms and roles in pathology
14. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease
15. Apoptosis and cancer
16. Internucleosomal DNA cleavage should not be the sole criteria for identifying apoptosis
17. Cell death by apoptosis in epidermal biology
18. Premature p34cdc2 activation required for apoptosis
19. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines
20. Induction of apoptosis in fibroblasts by c-myc protein
21. Social controls on cell survival and cell death
22. Hormone regulated apoptosis results from the reentry of differentiated prostate cell onto a defective cell cycle
23. Cytotoxic effects of cell cycle phase specific agents: results of cell cycle perturbations
24. Cellular signalling in programmed cell death (apoptosis)
25. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes
26. Protein kinase-C involvement in thymocyte apoptosis induced by hydrocortisone
27. Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes
28. The role of cytosolic Ca++ in cell injury, necrosis and apoptosis
29. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway
30. Apoptosis and signal transduction: clues to a molecular mechanism
31. Monoclonal antibody-mediated tumor regression by induction of apoptosis
32. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
33. A novel domain within the 55kd TNF receptor signals cell death
34. A novel protein domain required for apoptosis
35. Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin
36. Constitutive and induced expression of Apo-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
37. Anti-Fas on nonhematopoietic tumors: levels of Fas/Apo-1 and bcl-2 are not predictive of biological responsiveness
38. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
39. Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxicity
40. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
41. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
42. Lethal effect of the anti-Fas antibody in mice
43. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β in cultured uterine epithelial cells
44. Expression of transforming growth factor β in the rat ventral prostate during castration induced programmed cell death
45. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1
46. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor /31
47. Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McARH7777: a possible association with tissue transglutaminase expression
48. TGF-/3 gene transcription in normal and neoplastic liver growth
49. Transforming growth factor-β1 as a signal for induction of cell death by apoptosis
50. Activin induces cell death in hepatocytes in vivo and in vitro
51. Apoptosis
52. DNA fragmentation during apoptosis is caused by frequent single-strand cuts
53. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
54. 2+-dependent endonuclease from human spleen: purification, properties, and role in apoptosis
55. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis
56. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death)
57. Apoptosis is induced by transforming growth factor-β1 within 5 hours in regressing liver without significant fragmentation of the DNA
58. Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes
59. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis
60. Non-lysomal serine protease activity contributes to bile acid-induced apoptosis in hepatocytes
61. Induction of apoptosis in fibroblasts by Il-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
62. Degradation of cells dying by apoptosis leads to accumulation of ϵ(γ-glutamyl)lysine isodipeptide in culture fluid and blood
63. Tissue transglutaminase in cells undergoing apoptosis
64. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action
65. “Tissue” transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation
66. Expression of tissue transglutaminase in Balb-c 353 fibroblasts: effects on cellular morphology and adhesion
67. Terminal differentiation of cultured human epidemal cells
68. An involucrin-like protein in hepatocytes serves as a substrate for tissue transglutaminase during apoptosis
69. Characterization of the transglutaminase mediated large molecular weight polymer from rat liver; its relationship to apoptosis and its importance in carcinogenesis and tumour progression
70. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, campothecin, and other cytotoxic anticancer drugs: a cautionary note
71. The clearance of apoptotic cells in the liver is mediated by the asiaglycoprotein receptor
72. Galactose-specific receptor modulation related to the onset of apoptosis in rat liver
73. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis
74. Macrophage phagocytosis of aging neutrophils in inflammation
75. Bcl-2 initiates a new category of oncogenes: regulators of cell death
76. Bcl-2 and the regulation of programmed cell death
77. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species
78. Bcl-2 functions in an antioxidant pathway in apoptosis
79. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
80. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2 protects human B cells from programmed cell death
81. Overexpressed full-length human Bcl-2 extends the survival of baculovirus-infected SF9 insect cells
82. Conversion of lytic to persistent alphavirus infection by the bcl2 cellular oncogene
83. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver
84. Toward an understanding of the molecular mechanisms of physiological cell death
85. p53 gene mutation spectrum in hepatocellular carcinoma
86. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
87. The p53 tumour suppressor gene
88. p53, guardian of the genome
89. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
90. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6
91. p53-deficient mice are developmentally normal but susceptible to spontaneous tumours
92. Fifth Annual Pezcoller Symposium: Apoptosis
93. Expression of the proto-oncogene c-myc can lead to liver cell death [Abstract]
94. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas
95. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max
96. Induction of the TRPM-2 gene in cells undergoing programmed cell death
97. Hepatocyte apoptosis is triggered by galactosamine or cycloheximide, and associated with expression of the RP-8 gene [Abstract]
98. Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death
99. Extreme sensitivity of some intestinal crypt cells to X and gamma-irradiation
100. Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver
101. The streaming liver II. Hepatocyte life history
102. A quantitative evaluation of apoptotic bodies in rat liver
103. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation
104. Occurrence of cell death (apoptosis) during the involution of liver hyperplasia
105. Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus
106. LPS-induced apoptosis in Kupffer cells-a possible role in pathogenesis of sepsis [Abstract]
107. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide
108. The significance of cell death by apoptosis in hepatobiliary disease
109. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells
110. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters
111. Programmed cell death and its protective role with particular reference to apoptosis
112. Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis
113. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin
114. Molecular regulation of apoptosis: genetic controls on cell death
115. Wild-type p53 mediates apoptosis be E1A, which is inhibited by E1B
116. Histological patterns of prolonged hepatitis C infection
117. Mechanisms of class I restricted immunopathology
118. Cell death mechanisms and the immune system
119. A natural killer cell granule protein that induces DNA fragmentation and apoptosis
120. Necroinflammatory liver diseases
121. Electron microscopic observation of destruction of biliary epithelium in primary biliary cirrhosis
122. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection
123. An electron microscopic study of the mode of donor cell death in unmodified rejection of pig liver allografts
124. Ultrastructural lesions of bile ducts in primary biliary cirrhosis
125. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts
126. Recent advances in drug metabolism and hepatotoxicity
127. Definition of apoptosis and overview of its incidence
128. Microtubule antagonists activate programmed cell death (apoptosis) in cultured rat hepatocytes
129. 2+ accumulation and early DNA fragmentation with cell death
130. Mechanisms of FIAU induced hepatotoxicity [Abstract]
131. Rapid induction of apoptosis in rat liver by cycloheximide
132. An electron-microscope study of liver cell necrosis due to heliotrine
133. Apoptosis—the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity
134. 1,1-Dichloroethylene: an apoptotic hepatotoxin?
135. Mechanisms of acetaldehyde mediated growth inhibition delayed cell cycle progression and induction of apoptosis [Abstract]
136. Subcellular changes and apoptosis induced by ethanol in rat liver
137. Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes
138. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes
139. Hepatocellular degeneration and death
140. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
141. Isolation and purification of calcium- and magnesium-dependent endonuclease from rat liver nuclei
142. Purification and characterization of a major endonuclease from rat liver nuclei
143. Purification and some properties of a deoxyribonucleic acid endonuclease endogenous to rat liver chromatin
144. Purification and properties of an endonuclease endogenous to rat liver nuclei
145. A nuclease from rat-liver nuclei with endo- and exonucleolytic activity